首页> 外文OA文献 >PRS-02: Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST)

【2h】

PRS-02: Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST)

机译：PRS-02：吉非替尼（IRESSA）与多西紫杉醇联合铂类化学疗法治疗的局部晚期或转移性非小细胞肺癌患者：一项随机，开放标签的III期研究（INTEREST）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Douillard Jean-Yves; Kim Edward; Hirsh Vera; Mok Tony; Socinski Mark; Gervais Radj; Wu Yi-Long; Li Longyun; Sellers Mark; Lowe Elizabeth;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 吉非替尼治疗局部晚期或转移性非小细胞肺癌患者疗效及生存的临床预测因素——两项Ⅱ期临床研究的综合分析 [J] . 赵媛媛, 张阳, 赵洪云, 癌症（英文版） . 2009,第006期
2. Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum-based chemother [J] . J.Y. Douillard, . E.S. Kim, V Hirsh, European Journal of Cancer Supplements . 2007,第6期

机译：口服吉非替尼（IRESSA）与静注多西紫杉醇治疗局部晚期或转移性非小细胞肺癌的先前接受铂类化学疗法的患者的III期随机，开放标签，平行分组研究
3. 2LB Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum- based chemotherapy (INTEREST) [J] . J.Y.Douillard, E.S.Kim, V.Hirsh, European Journal of Cancer Supplements . 2007,第6期

机译：2LB口服吉非替尼（IRESSA）与静脉多西紫杉醇在先前接受过铂类化疗（INTEREST）的局部晚期或转移性非小细胞肺癌患者中进行的口服吉非替尼（IRESSA）与静脉多西紫杉醇随机对照试验
4. Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer. [J] . Cufer T, Vrdoljak E, Gaafar R, Anti-cancer drugs . 2006,第4期

机译：II期单项药物吉非替尼（IRESSA）或多西他赛为二线治疗的开放式随机研究（SIGN），用于晚期（IIIb或IV期）非小细胞肺癌患者。
5. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
6. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
7. A phase III randomized open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer [O] . R J Kelly, F A Shepherd, A Krivoshik, -1

机译：晚期IIIB / IV期非小细胞肺癌患者中ASP8273与厄洛替尼或吉非替尼的III期随机开放标签研究
8. B3-01: A randomized Phase III study to compare the overall survival of gefitinib (IRESSA) versus docetaxel in Japanese patients with previously treated advanced non-small-cell lung cancer [O] . Sekine Ikuo, Ichinose Yukito, Nishiwaki Yutaka, 2007

机译：B3-01：一项随机III期研究，比较吉非替尼（IRESSA）与多西他赛在日本先前接受过治疗的晚期非小细胞肺癌患者中的总体生存率

PRS-02: Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST)

著录项

相似文献

相关主题

期刊订阅